MDS Research Fund Grant Highlights

Please visit the Myelodysplastic Syndromes (MDS) Research Fund page for more information.

University of Pennsylvania

Role of the “Immunome” in response and failure of allogeneic stem cell transplantation for MDS 2021 Overview The Vera and Joseph Dresner Foundation granted University…

St. Jude Children’s Research Hospital

Elucidating mechanisms of genomic rescue in SAMD9/SAMD9L-related MDS predisposition 2021 Overview St. Jude Children’s Research Hospital was awarded a $250,000 grant over two years to…

University of Texas – MD Anderson Cancer Center

The role of HIPK2 in the pathogenesis of therapy-related myelodysplastic syndrome with del7q 2021 Overview The Vera and Joseph Dresner Foundation granted University of Texas…

Johns Hopkins University

The Role of Short Telomeres in Age-Related Myelodysplastic Syndromes 2020 Overview The Vera and Joseph Dresner Foundation granted Johns Hopkins University a $250,000 grant over…

Fred Hutchinson Cancer Research Center

Therapeutic Targeting of Aberrant mRNA Splicing in Myelodysplastic Syndromes 2020 Overview Fred Hutchinson Cancer Research Center was awarded a $250,000 grant over two years to…

Yale University

Exploiting DNA Repair Defects in IDH Mutant MDS via Combination Therapies 2020 Overview The Vera and Joseph Dresner Foundation granted Yale University a $500,000 grant…

Memorial Sloan-Kettering Cancer Center

Phase II Study of a Geriatric Vulnerability Based, Personalized Allogeneic Hematopoietic Transplantation Strategy for Older, Vulnerable Patients with Myelodysplastic Syndrome. 2019 Overview Memorial Sloan-Kettering Cancer…

The Cleveland Clinic Foundation

The Role of DDX41 in MDS 2019 Overview The Vera and Joseph Dresner Foundation granted The Cleveland Clinic Foundation a $500,000 grant over two years…

University of Miami

Targeted Maintenance of TET Activity in MDS Progression and Treatment 2019 Overview The Vera and Joseph Dresner Foundation granted University of Miami a $250,000 grant…

H. Lee Moffitt Cancer Center

Delineation of Immune Evasive Mechanisms Driving Poor Outcome in TP53 Mutant Myelodysplatic Syndromes 2018 Overview The Vera and Joseph Dresner Foundation granted H Lee Moffitt…

The Cleveland Clinic Foundation

Molecularly targeted agents in myelodysplastic syndrome 2018 Overview The Vera and Joseph Dresner Foundation granted The Cleveland Clinic Foundation a $250,000 grant for early career…

University of Rochester

Role for bone marrow mesenchymal populations in modulating Interleukin 1 signaling in myelodysplastic syndrome 2018 Overview The Vera and Joseph Dresner Foundation granted University of…

Dana-Farber Cancer Institute

A New Paradigm of Transfusion Support for Patients with Myelodysplastic Syndromes 2017 Overview The Dresner Foundation granted Dana-Farber Cancer Institute a $500,000 grant for established…

Dana-Farber Cancer Institute

The Impact of Somatic STAG2 Mutations on MDS Transformation in GATA2 Deficiency Syndrome 2017 Overview Dana-Farber Cancer Institute received a $287,500 grant to support early…

Memorial Sloan-Kettering Cancer Center

The Clinical Impact of MDS Stem Cells in Patients Undergoing Allogeneic Transplant 2017 Overview Memorial Sloan-Kettering Cancer Center was awarded a $287,500 grant to support…